Stanford W, Spivey C G, Larsen G L, Alexander J A, Besich W J
J Thorac Cardiovasc Surg. 1976 Sep;72(3):441-9.
Three thousand patients with primary carcinoma of the lung entered in the Armed Forces Central Medical Registry are reported. Forty-one per cent had squamous cell, 28.5 per cent adenocarcinoma, 25.2 per cent small cell/undifferentiated, and 4.9 per cent miscellaneous cell types. When first seen, 71.1 per cent had no organ metastases and 50.6 per cent no lymph node metastases. Over-all survival rate was 18.2 per cent at 5 years and 14.5 per cent at 10 years. Survival following definitive resection, palliative resection, definitive radiation, palliative radiation, and chemotherapy was determined both in the presence of mediastinal nodal involvement and in the absence of mediatinal nodal involvement. Where resection for cure could be carried out, 5 year survival rates of 48.8 per cent were possible. The factors affecting this improved outlook in our military population are discussed and, in general, appear to be related to a ready accessibility of medical care and the necessity, because of global commitments, of establishing an early diagnosis. Cell type ecerted some influence on survival, but the major determinant appeared to be the absence of involved nodes at the time of the operation.
报告了武装部队中央医疗登记处登记的3000例原发性肺癌患者。其中41%为鳞状细胞癌,28.5%为腺癌,25.2%为小细胞/未分化癌,4.9%为其他细胞类型。初诊时,71.1%无器官转移,50.6%无淋巴结转移。5年总生存率为18.2%,10年为14.5%。在有和无纵隔淋巴结受累的情况下,分别确定了根治性切除、姑息性切除、根治性放疗、姑息性放疗和化疗后的生存率。在可行根治性切除的情况下,5年生存率可达48.8%。讨论了影响我国军人这种改善预后的因素,总体而言,这些因素似乎与医疗服务的便捷可及性以及由于全球任务需要而进行早期诊断的必要性有关。细胞类型对生存率有一定影响,但主要决定因素似乎是手术时无受累淋巴结。